Clinical trialPhase 3Terminated
Carbon Ion RT for Locally Advanced Pancreatic Cancer
A Prospective, Randomized, Phase 3 Trial of Carbon Ion Radiation Therapy Versus Standard Care for Locally Advanced Pancreatic Cancer
- Outcome
- Stopped earlyStudy administratively closed out by the Einstein IRB. NO US enrolling sites. (Enrollment)
- Phase
- Phase 3
- Status
- Terminated
- Study type
- Interventional
- Start
- 1 November 2020
- Ended
- 24 August 2022
- Enrollment
- 5 participants
- Sites
- 1
- Primary outcomes
- Overall survival duration
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 5 January 2024
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
This is an open-label randomized trial. Subjects will be randomized in a 2:1 ratio to receive carbon ion radiotherapy versus standard care for locally advanced pancreatic cancer. Subjects who receive carbon ion radiotherapy may receive additional chemotherapy afterwards, at the discretion of the treating physicians. Subjects on the control arm are also expected to receive chemotherapy, using a regimen selected by the treating physicians. Subjects on the control arm will not receive upfront radiotherapy but may receive radiotherapy (not carbon ion radiotherapy) if disease progression occurs.